AB-FUBINACA is a designer drug that acts as a potent agonist for the cannabinoid receptors. It was originally developed by Pfizer in 2009 as an analgesic medication but was never pursued for human use.
Cas No: 1185282-01-2
Formula: C20H21FN4O2
IUPAC: N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
Appearance:
Purity: 99.99%